EMT and inflammation: inseparable actors of cancer progression

M Suarez‐Carmona, J Lesage, D Cataldo… - Molecular …, 2017 - Wiley Online Library
Tumors can be depicted as wounds that never heal, and are infiltrated by a large array of
inflammatory and immune cells. Tumor‐associated chronic inflammation is a hallmark of …

Transforming growth factor-β-induced cell plasticity in liver fibrosis and hepatocarcinogenesis

I Fabregat, D Caballero-Díaz - Frontiers in oncology, 2018 - frontiersin.org
The Transforming Growth Factor-beta (TGF-β) family plays relevant roles in the regulation of
different cellular processes that are essential for tissue and organ homeostasis. In the case …

[HTML][HTML] TGF-β signaling in liver, pancreas, and gastrointestinal diseases and cancer

NR Gough, X Xiang, L Mishra - Gastroenterology, 2021 - Elsevier
Genetic alterations affecting transforming growth factor–β (TGF-β) signaling are
exceptionally common in diseases and cancers of the gastrointestinal system. As a regulator …

TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer

L Caja, F Dituri, S Mancarella… - International journal of …, 2018 - mdpi.com
Transforming growth factor-β (TGF-β) is a cytokine essential for the induction of the fibrotic
response and for the activation of the cancer stroma. Strong evidence suggests that a strong …

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer

MA Papadaki, G Stoupis, PA Theodoropoulos… - Molecular Cancer …, 2019 - AACR
Circulating tumor cells (CTCs) bearing phenotypes related to cancer stem cells (CSCs) and
epithelial-to-mesenchymal transition (EMT) have been identified in breast cancer; however …

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside

Y Yin, W Feng, J Chen, X Chen, G Wang… - … hematology & oncology, 2024 - Springer
Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy with high incidence,
recurrence, and metastasis rates. The emergence of immunotherapy has improved the …

The TGF-β pathway: a pharmacological target in hepatocellular carcinoma?

E Gonzalez-Sanchez, J Vaquero… - Cancers, 2021 - mdpi.com
Simple Summary Transforming Growth Factor-beta (TGF-β) signaling is crucial to maintain
tissue homeostasis. Alterations in TGF-β signaling impact tissue functions and favor the …

Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial–mesenchymal transition

Y Chen, W Tan, C Wang - OncoTargets and therapy, 2018 - Taylor & Francis
Cancer stem cells are a small population of cells with the potential for self-renewal and multi-
directional differentiation and are an important source of cancer initiation, treatment …

TGF-β as multifaceted orchestrator in HCC progression: signaling, EMT, immune microenvironment, and novel therapeutic perspectives

F Dituri, S Mancarella, A Cigliano… - Seminars in liver …, 2019 - thieme-connect.com
Therapeutic attempts to treat hepatocellular carcinoma (HCC) frequently result in a poor
response or treatment failure. The efficacy of approved drugs and survival expectancies is …

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential

YM Tsui, LK Chan, IOL Ng - British journal of cancer, 2020 - nature.com
Cancer stemness, referring to the stem-cell-like phenotype of cancer cells, has been
recognised to play important roles in different aspects of hepatocarcinogenesis. A number of …